Niceron Tablet 30 mg (Nisergoline)

Adult dose

* 5 mg, 10 mg Adults: Administer 5 ∼ 10 mg of nicergoline orally 2 ∼ 3 times daily before meals. Adjust the dose as appropriate according to symptoms. * 30 mg Adults: Administer 30 mg of nicergoline orally once daily before a meal. If the desired effect is not achieved at this dose, it may be increased to 60 mg. The dose may be reduced after symptoms improve. Reduce the dose in patients with impaired renal function (serum creatinine >175 µmol/L) (2 mg/dL).

This medication should not be used in certain patients. People allergic to this drug or ergot alkaloids should not take it. Patients with acute cardiac issues or sudden bleeding should also avoid this medication. Caution is advised for individuals taking drugs that act on the sympathetic nervous system and for patients with very slow heart rates. Patients who have not finished hemostasis after a cerebral hemorrhage and those with orthostatic hypotension should avoid this medication. Patients with slight bradycardia or kidney issues should take this drug with caution. This medication may rarely cause symptoms such as dyspepsia, diarrhea, constipation, vomiting, abdominal pain, dry mouth, increased ALT, increased AST, dizziness, orthostatic intolerance, hypertension, elevated blood uric acid, hypotension, drowsiness, lethargy, headache, fatigue, insomnia, rash, itching, flushing, hot flashes, nightmares, mood changes, and dyspepsia. When used together with antihypertensives, the effect may be intensified, so blood pressure should be frequently monitored. It may affect uric acid levels, so patients with a history of gout should be cautious. After taking this medication, driving or operating machinery should be done carefully. This drug is metabolized in the liver, which may cause drug interactions. Particular caution is required when taken with antihypertensives. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of taking this medication. Animal studies have reported potential harm to the fetus, so it is advisable to avoid this medication during pregnancy. If breastfeeding, this drug may pass into breast milk, so it is preferable to avoid taking it or to discontinue breastfeeding. Elderly patients may have decreased bodily functions, so caution is necessary in adjusting the dosage. Safety for children has not been confirmed, so it is advisable to avoid using this drug in this population. In case of overdose, blood pressure may temporarily drop, so blood pressure changes should be closely monitored and necessary actions taken. This medication should be kept out of reach of children and stored in its original container to maintain quality.

Loss of appetite, diarrhea, constipation, nausea, vomiting, incidental upper abdominal pain or cramps, thirst, elevated ALT, elevated AST, dizziness, orthostatic hypotension, hypertension, elevated blood uric acid, hypotension, drowsiness, fatigue, headache, tinnitus, exhaustion, insomnia, rash, urticaria, itching, flushing, warmth sensation, nightmares, mood changes, dyspepsia

This medication should be stored in a tightly sealed container that blocks light and kept at a temperature between 1 to 30 degrees Celsius. Storing in this manner can help maintain the drug's effectiveness and prevent deterioration.

Appearance

Yellow round film-coated tablets

Package unit

100 tablets/bottle, 30 tablets/bottle